Search | IOVS | ARVO Journals

View

Showing 1 – 2 of 2

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Cost-effectiveness of Choroideremia Gene Therapy

Celine-Lea Halioua-Haubold; Jasleen Kaur Jolly; David A Brindley; Rafael Pinedo-Villanueva; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5461. doi:

ARVO Annual Meeting Abstract July 2018

A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs)

Celine-Lea Halioua-Haubold; Jasleen Jolly; Rafael Pinedo Villanueva; David Brindley; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3897. doi:

Advertisement